You are on your way to the Revvity Omics Roadmap2Rare landing page!

Sanofi Canada is working in collaboration with Revvity Omics to offer the Roadmap2Rare Diagnostic Program (R2RDP), a no-charge genetic and biochemical testing program available to Canadian clinicians. This page will direct you to the Revvity Omics website, where you can:

  • Review the test requisition forms (TRFs), which contain test descriptions and eligibility criteria
  • Order a kit for specimen collection
  • Request laboratory coordination of mobile phlebotomy
  • Find detailed R2RDP information
  • Contact the Revvity Omics laboratory team
Continue to the Revvity Omics Roadmap2Rare landing page
Skip to main content

Sanofi logo
Roadmap2Rare logo
HOME
DIAGNOSIS
  • DIAGNOSIS
  • Pompe Disease | What is Pompe Disease?
  • Fabry Disease | What is Fabry Disease?
  • Gaucher Disease Testing | What is Gaucher Disease?
  • ASMD Disease | ASMD Disease Testing
  • Mucopolysaccharidosis I Disease Testing
TREATMENT & MONITORING
PATIENT SUPPORT
FAQ
RESOURCES
CONTACT US
  • EN
  • FR
Roadmap2Rare logo
  • EN
  • FR
Roadmap2Rare logo
HOME
DIAGNOSIS
  • DIAGNOSIS
  • Pompe Disease | What is Pompe Disease?
  • Fabry Disease | What is Fabry Disease?
  • Gaucher Disease Testing | What is Gaucher Disease?
  • ASMD Disease | ASMD Disease Testing
  • Mucopolysaccharidosis I Disease Testing
TREATMENT & MONITORING
PATIENT SUPPORT
FAQ
RESOURCES
CONTACT US

Privacy Policy

Terms and Conditions

Contact us

Cookie Policy

Accesibility

Sanofi Canada logo

Last updated: April 2026
MAT-CA-22600433 (v1.0)

© sanofi-aventis Canada Inc. 2026 - All rights reserved

    Follow us

You are about to leave the site

You are about to leave the
www.roadmap2rare.ca site.
info warning
Back Continue